CLINICAL_TRIALS
trial_result
· 2025-03-19
Clinical Trial Update: Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain [Phase 3]
Summary
Termination of an extension Phase 3 trial evaluating linzagolix for endometriosis-associated pain, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Endometriosis | Phase 3 | Status: TERMINATED | Results posted: 2025-03-19